Dr. Ellie Kelepouris, MD

Dr. Kelepouris practices at Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania.

Dr. Kelepouris' NPI, 1790773547, was assigned on October 6, 2005. Dr. Kelepouris holds Pennsylvania license MD038124L.

Dr. Kelepouris' primary practice is Hospital of the University of Pennsylvania, at 3400 Spruce St, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 662-6289.

Dr. Kelepouris' primary practice is Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania. Dr. Kelepouris is also affiliated with Penn Presbyterian Medical Center. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Kelepouris to 1 more dialysis center, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kelepouris practices, 4 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Kelepouris' primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Kelepouris is licensed in Pennsylvania.

CMS data shows 201 Medicare services from Dr. Kelepouris across 6 procedure codes in 2024, for 110 Medicare patients. Medicare paid $11,262 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 110 Medicare patients who saw Dr. Kelepouris in 2024. The largest group is 65 to 74, with 47 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 28% are also on Medicaid. Their average risk score is 4.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kelepouris' median patient age at 63, with 46% women.

In 2024, Dr. Kelepouris wrote 793 Medicare Part D claims for 74 patients. 84% of them were for generic drugs. CMS names the drug for 661 of them, across 24 drugs with 11 or more claims each, at $77,200 in total drug cost. In 2023, CMS named 595 claims across 24 drugs.

Dr. Kelepouris accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kelepouris as offering telehealth.

CMS Open Payments shows 504 general payments to Dr. Kelepouris from 27 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 39% of the total. Relypsa, Inc. paid the most, $80,991.